Glucocorticoid inhibition of adjuvant arthritis synovial macrophage nitric oxide production: Role of lipocortin I

Clinical and Experimental Immunology

Volumn 111, Issue 1, 1998, Pages 117-122

  Yang, Y H ^a   Hutchinson, P ^a   Santos, L L ^a   Morand, E F ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

Adjuvant; Arthritis; Glucocorticoid; Lipocortin 1; Macrophage; Nitric oxide

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; LIPOCORTIN 1; MONOCLONAL ANTIBODY; NITRIC OXIDE;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FLOW CYTOMETRY; IMMUNOBLOTTING; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYNOVIUM;

ANIMALS; ANNEXIN A1; ARTHRITIS, EXPERIMENTAL; GLUCOCORTICOIDS; MACROPHAGES; MALE; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; SYNOVIAL MEMBRANE;

EID: 0031883069     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00438.x     Document Type: Article

References (49)

1. Sano H, Hla T, Maier JA et al. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest 1992; 89:97-108.
2. Santos L, Tipping PG. Attenuation of adjuvant arthritis in rats by treatment with oxygen radical scavengers. Immunol Cell Biol 1994; 72: 406-14.
3. Sakurai H, Kohsaka H, Liu M-F et al. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 1995; 96:2357-63.
4. Grabowski PS, MacPherson H, Ralston SH. Nitric oxide production in cells derived from the human joint. Br J Rheumatol 1996; 35:207-12.
5. Santos LL, Morand EF, Holdsworth SR. Suppression of adjuvant arthritis and synovial macrophage inducible nitric oxide by N-iminoethyl-l-ornithine, a nitric oxide synthase inhibitor. Inflammation 1997; 21:299-311.
6. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43:109-42.
7. Stefanovic-Racic M, Stadler J, Georgescu HI, Evans CH. Nitric oxide synthesis and its regulation by rabbit synoviocytes. J Rheumatol 1994; 21:1892-8.
8. Ralston SH, Todd D, Helfrich M, Benjamin N, Grabowski PS. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 1994; 135:330-6.
9. Murrell GA, Jang D, Williams RJ. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995; 206:15-21.
10. Taskiran D, Stefanovic-Racic M, Georgescu H, Evans C. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem Biophys Res Commun 1994; 200:142-8.
11. Kaur H, Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Letters 1994; 350:9-12.
12. Farrell AJ, Blake DR, Palmer RM, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992; 51:1219-22.
13. Morand EF, Goulding NJ. Glucocorticoids in rheumatoid arthritis -mediators and mechanisms. Br J Rheumatol 1993; 32:816-9.
14. Moncada S, Palmer RMJ. Inhibition of the induction of nitric oxide synthase by glucocorticoids: yet another explanation tor their anti-inflammatory effects? TIPS 1991; 12:130-1.
15. Hukkanen M, Hughes FJ, Buttery LD et al. Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity. Endocrinology 1995; 136:5445-53.
16. Stichtenoth DO, Fauler J, Zeidler H, Frolich JC. Urinary nitrate excretion is increased in patients with rheumatoid arthritis and reduced by prednisolone. Ann Rheum Dis 1995; 54:820-4.
17. Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995; 333:142-6.
18. Vishwanath BS, Frey FI, Bradbury M, Dallman MF, Frey BM. Adrenalectomy decreases lipocortin-1 messenger ribonucleic acid and tissue protein content in rats. Endocrinology 1992; 130:585-91.
19. Goulding NJ, Godolphin JL, Sharland PR et al. Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone. Lancet 1990; 335:1416-8.
20. Morand EF, Jefferiss CM, Dixey J, Mitra D, Goulding NJ. Impaired glucocorticoid induction of mononuclear leukocyte lipocortin 1 in rheumatoid arthritis. Arthritis Rheum 1994; 37:207-11.
21. Perretti M, Flower RJ. Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1. J Immunol 1993; 150:992-9.
22. Curey F, Forder R, Edge MD et al. Lipocortin-1 fragment modifies the pyrogenic actions of cytokines in rats. Am J Physiol 1990; 259:R266-R269.
23. Cirino G, Peers SH, Flower RJ, Browning JL, Pepinsky RB. Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test. Proc Natl Acad Sci USA 1989; 86:3428-32.
24. Errasfa M, Russo-Marie F. A purified lipocortin shares the anti-inflammatory effect of glucocorticosteroids in vivo in mice. Br J Pharmacol 1989; 97:1051-8.
25. Yang YH, Leech M, Hutchinson P, Holdworth SR, Morand EF. Anti-inflammatory effect of lipocortin 1 in experimental arthritis. Inflammation 1997; in press.
26. Perretti M, Ahluwalia A, Harris JG, Harris HJ, Wheller SK, Flower RJ. Acute inflammatory response in the mouse: exacerbation by immunoneutralization of lipocortin 1. Brit J Pharmacol 1996; 117:1146-54.
27. Kim KM, Kim DK, Park YM, Kim CK, Na DS. Annexin-I inhibits phospholipase A2 by specific interaction, not by substrate depletion. FEBS Letters 1994; 343:251-5.
28. Wu C-C, Croxtall JD, Perretti M et al. Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat. Proc Natl Acad Sci USA 1995; 92:3473-7.
29. Pepinsky RB, Sinclair LK, Dougas I, Liang C-M, Lawton P, Browning JL. Monoclonal antibodies to lipocortin-1 as probes for biological function. FEBS Letters 1990; 261:247-52.
30. Oswald IP, Guzzinelli RT, Sher A, James SL. IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. J Immunol 1992; 148:3578-82.
31. Morand EF, Hutchinson P, Hargreaves A, Goulding NJ, Boyce NW, Holdsworth SR. Detection of intracellular lipocortin 1 in human leukocyte subsets. Clin Immunol Immunopathol 1995; 76:195-202.
32. Alvaro-Gracia JM, Zvaifler NJ, Brown CB, Kaushansky K, Firestein GS. Cytokines in chronic inflammatory arthritis VI. Analysis of the synovial cells involved in granulocyte-macrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumour necrosis factor-α. J Immunol 1991; 146:3365-71.
33. Chu CQ, Field M, Feldman M, Maini RN. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991; 34:1125-32.
34. Kinne RW, Schmidt CB, Buchner E, Hoppe R, Nurnberg E, Emmrich F. Treatment of rat arthritides with clodronate-containing liposomes. Scand J Rheumatol 1995; 101:91-97.
35. Fuller PJ, Verity K. Somatostatin gene expression in the thymus gland. J Immunol 1989; 143:1015-7.
36. Suarez F, Rothhut B, Comera C, Touqui L, Marie FR, Silve C. Expression of annexin I, II, V, and VI by rat osteoblasts in primary culture: stimulation of annexin I expression by dexamethasone. J Bone Miner Res 1993; 8:1201-10.
37. Higuchi H, Katoh N, Miyamoto T, Uchida K, Yuasa A, Takahashi K. Dexamethasone-induced haptoglobin release by call liver parenchymal cells. Am J Vet Res 1994; 55:1080-5.
38. Newman SP, Flower RJ, Croxtall JD. Dexamethasone suppression of IL-1β induced cyclooxygenase 2 expression is not mediated by lipocortin 1 in A549 cells. Biochem Biophys Res Commun 1994; 202:931-9.
39. Goulding NJ, Guyre PM. Regulation of inflammation by lipocortin 1. Immunol Today 1992; 13:295-7.
40. Goulding NJ, Guyre PM. Glucocorticoids, lipocortins and the immune response. Curr Opin Immunol 1993; 5:108-13.
41. Goulding NJ, Jefferiss CM, Pan L, Rigby WF, Guyre PM. Specific binding of lipocortin 1 (annexin I) to monocytes and neutrophils is decreased in rheumatoid arthritis. Arthritis Rheum 1992; 35:1395-7.
42. Goulding NJ, Pan LY, Wardwell K, Guyre VC, Guyre PM. Evidence for specific annexin-I binding proteins on human monocytes. Biochem J 1996; 316:593-7.
43. -2 generation by dexamethasone is mimicked by lipocortin 1 in alveolar macrophages. J Clin Invest 1989; 83:1936-40.
44. Halliwell B. Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann Rheum Dis 1995; 54:505-10.
45. Wei XQ, Charles IG, Smith A et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995; 375:408-11.
46. Yang YH, Hutchinson P, Leech M, Morand EF. Exacerbation of adjuvant arthritis by adrenalectomy is associated with reduced leukocyte lipocortin 1. J Rheumatol 1997; in press.
47. Szabo C, Thiemermann C, Wu C-C, Perretti M, Vane JR. Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci USA 1994; 91:271-5.
48. Goulding NJ, Dixey J, Morand EF et al. Differential expression of annexins-I, -II, -IV and -VI in synovium. Ann Rheum Dis 1995; 54: 841-5.
49. Podgorski MR, Goulding NJ, Hall ND, Flower RJ, Maddison PJ. Autoantibodies to lipocortin 1 are associated with impaired corticosteroid responsiveness in rheumatoid arthritis. J Rheumatol 1992; 19: 1668-71.